Selling a Beauty Brand: What the Elemis Sale to PAI Teaches Founders

On 4 November 2026, L’Occitane Group and the investment firm PAI Partners announced an agreement under which PAI is to acquire Elemis, the British premium skincare brand the group has owned since 2019. According to the announcement, financial terms have not been disclosed and completion is expected in the first quarter of 2027, subject to the usual regulatory approvals. For a founder or executive of a cosmetics brand, the news goes beyond a financial item: it shows how a beauty asset is examined, valued and handed over when the time to sell comes.

Elemis moves from L’Occitane to PAI: what was announced

Let us start with what is established. L’Occitane Group announced in January 2019 that it was acquiring Elemis for 900 million dollars. Nearly eight years later, the group is selling the brand to an investment firm. The price of this new transaction has not been made public, and we deliberately do not repeat any valuation put forward elsewhere: as long as no figure appears in a statement from the parties, it is a rumour, not data. Since closing has not taken place, Elemis remains, at the date of this article, within the L’Occitane Group perimeter.

The second public element concerns the buyer’s intentions. PAI says it wants to accelerate the brand’s development in the United States, pursue growth in selected international markets, strengthen its digital presence and selective premium distribution, while continuing to invest in the range and in innovation. These priorities read like a classic brief for an established skincare brand: widen the geography, consolidate the most profitable channels and feed the catalogue. They also outline, by implication, the points on which a buyer expects evidence before signing.

Why an investment firm is interested in an established skincare brand

An investment firm does not buy a brand to own it, but to grow it and then resell it on good terms. This reasoning explains the interest in brands that are already recognised, present across several channels and backed by a loyal customer base: the start-up risk is behind them and the growth levers are identifiable. This is our reading, not a statement from PAI, but it sheds light on the logic of many beauty transactions seen over the past two years, from acquisitions of independent brands to portfolio disposals by large groups.

The other lesson lies in the channel mix. Elemis combines a prestige skincare positioning with a spa heritage, and is distributed both online and through selective points of sale. For a buyer, this diversity is reassuring as much as it complicates the analysis: each channel has its own margins, payment terms, brand requirements and dependency risks. A brand that can break down its results precisely by channel and by country, and explain why it chooses one partner over another, sells more easily and more calmly than one that tells a good story without tables to back it up.

The exit logic also deserves attention. A fund generally holds a brand for a few years, then seeks to resell it to an industrial group or another investor. From the moment it buys, it therefore reasons as tomorrow’s seller: what it examines on the way in will be examined again on the way out, by someone else and with the same rigour. A brand whose files, trademark registrations and contracts are clean at the time of sale remains easy to resell afterwards, which increases the value the investor is prepared to grant it from the start.

What a buyer examines before signing

Before any firm offer, the buyer carries out due diligence, that is, a prior acquisition audit: a methodical check of a company’s or brand’s accounts, contracts, intellectual property, compliance and risks, meant to confirm what the seller has presented and to adjust the price or the warranties accordingly. Its scope varies with the transaction, but the same themes come back almost every time the asset is a beauty brand, whatever its size or history.

• Quality of growth: revenue and margins by channel, country and range, repeat purchasing, weight of promotions.
• Dependency: share of the main retailers, platforms and a small number of products in sales.
• Intellectual property: trademark registered in each target market, clear ownership, no dispute or troublesome prior right.
• Product compliance: up-to-date files, notifications consistent with the markets actually served, documented claims.
• Supply chain: subcontractors, manufacturing contracts, quality and continuity of supply.

For an SME or a designer brand, the difficulty rarely lies in a lack of information, but in its dispersion: figures sit in a spreadsheet, product files with a service provider, trademark filings with an adviser, contracts with the founder. Bringing these elements together into a coherent whole is the first step of serious preparation. It takes time, it involves several teams, and it is easier to carry out when the brand is not yet in negotiation.

None of these points is spectacular, and that is precisely what makes them decisive. A weakness on one of them does not always cause a sale to fail, but it almost always results in tougher negotiation: a lower price, a retention on payment, broader liability warranties, a later closing date. A seller who discovers these issues when the buyer raises them loses control of the narrative, whereas one who has dealt with them beforehand presents them as matters already under control.

In the field: what is prepared months before a sale

At Clear, an EU / UK / US cosmetic regulatory compliance firm, we support cosmetics brands day to day, and we see the same weaknesses come back when one of them prepares for a sale, a fundraising or a distribution partnership. The product file (PIF, or Product Information File) has not been updated after a reformulation. The Responsible Person named on the packaging no longer matches the company’s reality. Notifications do not cover all the markets where the brand already sells. Marketing claims have evolved faster than the evidence behind them.

It is this less visible part of the asset that the buyer always ends up opening. A regulatory due diligence carried out before the sale allows you to correct what can be corrected, document what cannot, and face the buyer with an honest overview rather than grey areas. The same work also helps secure a distribution partnership or an export development. It is usefully completed by a review of brand protection, market by market, because a name that cannot be used abroad weighs directly on the value of the asset.

This preparation is as much about organisation as about technique. A brand sold on good terms is often one whose responsibilities are clear: who holds the files, who validates the claims, who follows the manufacturing contracts, who knows the exact status of trademark filings. When these answers fit in a table kept up to date, the discussion with a buyer or an investor changes in nature. The issues specific to companies in the sector are detailed on the page dedicated to the cosmetics industry.

What this transaction does not prove

It would be misleading to draw a general rule from it. Since Elemis’s price is not known, the multiple paid cannot be measured, nor the transaction compared with others. A large brand sold by a group managing a portfolio is not a brand founded five years ago by a team of three. Investment funds are not interested in every brand either, and a sale is only one possible path: some brands choose to stay independent, to raise minority funding or to enter a distribution partnership.

What the announcement does illustrate, however, is the mechanics: a brand is handed over all the better when it can demonstrate, with figures and documents, where its growth comes from and what secures it. This demonstration is prepared months in advance and cannot be improvised in a data room opened in a hurry, under the pressure of a signing timetable. It also protects the executive: one who knows their own files negotiates from a position of strength, whereas one who discovers them at the same time as the buyer endures the discussion.

In short: selling your beauty brand means selling an asset that the buyer will audit in detail. The clearer and more up to date the results by channel, the registered trademarks, the product files and the contracts, the faster the transaction and the better the price holds up in negotiation. The agreement announced on 4 November 2026 for Elemis is a reminder that even an established brand goes through this examination.

If you are considering selling your brand, opening your capital or simply checking what a buyer would find in your files, the Clear team can carry out a regulatory review and help you turn it into an action plan: contact us to discuss it.